Corcept Therapeutics, Inc. (CORT)
68.51
+1.86
(+2.79%)
USD |
NASDAQ |
May 28, 16:00
69.03
+0.52
(+0.76%)
After-Hours: 19:10
Corcept Therapeutics Research and Development Expense (Annual) : 254.91M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Merck & Co., Inc. | 12.51B |
| Supernus Pharmaceuticals, Inc. | 104.13M |
| Assertio Holdings, Inc. | 1.69M |
| Nektar Therapeutics | 117.07M |
| Pfizer Inc. | 10.25B |